These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
486 related items for PubMed ID: 18511570
1. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. Bougeard G, Sesboüé R, Baert-Desurmont S, Vasseur S, Martin C, Tinat J, Brugières L, Chompret A, de Paillerets BB, Stoppa-Lyonnet D, Bonaïti-Pellié C, Frébourg T, French LFS working group. J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570 [Abstract] [Full Text] [Related]
2. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ. J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432 [Abstract] [Full Text] [Related]
3. Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene. Bougeard G, Brugières L, Chompret A, Gesta P, Charbonnier F, Valent A, Martin C, Raux G, Feunteun J, Bressac-de Paillerets B, Frébourg T. Oncogene; 2003 Feb 13; 22(6):840-6. PubMed ID: 12584563 [Abstract] [Full Text] [Related]
4. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Finkova A, Vazna A, Hrachovina O, Bendova S, Prochazkova K, Sedlacek Z. Cancer Genet Cytogenet; 2009 Aug 13; 193(1):63-6. PubMed ID: 19602465 [Abstract] [Full Text] [Related]
5. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DG, Birch JM. Cancer Res; 1997 Aug 01; 57(15):3245-52. PubMed ID: 9242456 [Abstract] [Full Text] [Related]
6. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA. Cancer Res; 2003 Oct 15; 63(20):6643-50. PubMed ID: 14583457 [Abstract] [Full Text] [Related]
11. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, Tricker KJ, Varley JM. Oncogene; 1998 Sep 03; 17(9):1061-8. PubMed ID: 9764816 [Abstract] [Full Text] [Related]
12. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene. Varley JM, Thorncroft M, McGown G, Appleby J, Kelsey AM, Tricker KJ, Evans DG, Birch JM. Oncogene; 1997 Feb 20; 14(7):865-71. PubMed ID: 9047394 [Abstract] [Full Text] [Related]
13. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome. Barlow JW, Mous M, Wiley JC, Varley JM, Lozano G, Strong LC, Malkin D. Cancer Epidemiol Biomarkers Prev; 2004 Aug 20; 13(8):1403-6. PubMed ID: 15298965 [Abstract] [Full Text] [Related]
14. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. Bendig I, Mohr N, Kramer F, Weber BH. Cancer Genet Cytogenet; 2004 Oct 01; 154(1):22-6. PubMed ID: 15381368 [Abstract] [Full Text] [Related]
15. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Tabori U, Nanda S, Druker H, Lees J, Malkin D. Cancer Res; 2007 Feb 15; 67(4):1415-8. PubMed ID: 17308077 [Abstract] [Full Text] [Related]
16. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D. Cancer Res; 1994 Mar 01; 54(5):1298-304. PubMed ID: 8118819 [Abstract] [Full Text] [Related]